NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results GlobeNewswire November 05, 2025 – Marketing Authorization Applications for obicetrapib and FDC of obicetrapib plus ezetimibe accepted for review by European Medicines Agency – – BROOKLYN and BROADWAY pooled MACE analysis published in the Journal of the American College of Cardiology, while the BROADWAY […]
LM Funding America Announces October 2025 Production and Operational Update GlobeNewswire November 05, 2025 – Bitcoin treasury as of October 31, 2025 valued at $31.9 million or $2.70 per share1 TAMPA, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company,
CERo Therapeutics Initiates Second Cohort of Phase 1 Clinical Trial of CER-1236 in AML with Patient Receiving Significant Increase in Dosing GlobeNewswire November 05, 2025 SOUTH SAN FRANCISCO, Calif, Nov. 05, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc., (OTC PINK: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company pursuing new targets and
IBN Announces Latest Episode of The Stock2Me Podcast featuring President Ried Floco and CEO Jimmy Chan of Nightfood Holdings Inc. GlobeNewswire November 05, 2025 AUSTIN, Texas, Nov. 05, 2025 (GLOBE NEWSWIRE) — via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release
Radiopharmaceutical Market to Reach USD 14.11 Billion by 2034, Growing at 7.57% CAGR The global radiopharmaceutical market size is calculated at USD 7.32 billion in 2025 and is expected to reach around USD 14.11 billion by 2034, growing at a CAGR of 7.57% for the forecasted period. GlobeNewswire November 05, 2025 Ottawa, Nov. 05, 2025
New study paints clearest picture yet of women's struggle to get glasses, an inexpensive fix for the world's leading cause of vision impairment Many women around the world with vision problems need one very simple thing: a pair of glasses. But new research fromOrbis International reveals that women face more difficulty than men in getting
— Advances 45% Equity Sale at Sempra Infrastructure Partners — Expect 30%+ Increase in Oncor's 5-Year Capital Plan Sempra (NYSE: SRE) today reported third-quarter 2025 earnings, prepared in accordance with Generally Accepted Accounting Principles (GAAP), of $77 million or $0.12 per diluted share, compared to third-quarter 2024 GAAP earnings of $638 million or $1.00 per
Sabre Corporation (“Sabre”) (NASDAQ: SABR) today announced financial results for the quarter ended September 30, 2025. Sabre has posted its third quarter 2025 earnings release and earnings presentation to its Investor Relations webpage at investors.sabre.com/financial-information/quarterly results. The earnings release is also available on the Securities and Exchange Commission's website at www.sec.gov. As previously announced, Sabre
(NYSE:CDE),(NYSE:SM),(NYSE:GES),(NASDAQ:KMB), NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Coeur Mining, Inc. (NYSE: CDE)'s merger with New Gold Inc. Upon completion of the proposed transaction,
(NASDAQ:VBIX), Company Signed a Non-Binding Term Sheet for a security exchange between the parties Tel Aviv, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) — Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), a global developer of ad-tech innovative technologies, today announced the signing of a non-binding term sheet outlining the proposed terms for the acquisition of